Option Care Health (NASDAQ:OPCH) Announces Quarterly Earnings Results

Option Care Health (NASDAQ:OPCH) posted its earnings results on Tuesday. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.04, Briefing.com reports. Option Care Health had a net margin of 6.21% and a return on equity of 18.78%. The firm had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the previous year, the business posted $0.21 EPS. The business’s revenue was up 12.8% compared to the same quarter last year. Option Care Health updated its FY 2024 guidance to EPS.

Option Care Health Stock Down 2.6 %

Option Care Health stock traded down $0.79 during mid-day trading on Wednesday, hitting $29.80. The company had a trading volume of 429,736 shares, compared to its average volume of 1,247,277. The stock has a market cap of $5.18 billion, a price-to-earnings ratio of 20.90, a PEG ratio of 1.73 and a beta of 1.22. Option Care Health has a 1 year low of $24.23 and a 1 year high of $35.74. The company has a quick ratio of 1.33, a current ratio of 1.77 and a debt-to-equity ratio of 0.74. The business has a fifty day moving average of $32.19 and a 200 day moving average of $31.53.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the company’s stock in a transaction on Monday, February 26th. The shares were bought at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the completion of the purchase, the director now directly owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

OPCH has been the subject of a number of analyst reports. Jefferies Financial Group upped their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a report on Monday, March 4th. Barrington Research increased their price target on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “outperform” rating in a research report on Friday, February 23rd.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.